A novel DNA methylation 10-CpG prognostic signature of disease-free survival reveal that MYBL2 is associated with high risk in prostate cancer

Hou, XY; Zhang, YL; Han, SY; Hou, BX

Han, SY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Breast Surg, Shenyang 110001, Liaoning, Peoples R China.; Hou, BX (corresponding author), Shenyang Orthopaed Hosp, Dept Orthoped Surg, Shenyang 110044, Liaoning, Peoples R China.

EXPERT REVIEW OF ANTICANCER THERAPY, 2020; 20 (12): 1107

Abstract

Background Prostate cancer (PC) is the most common non-cutaneous malignancy among men in the western world. However, heterogeneity remains a pressing ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索